Skip to main content

Scopus BioPharma Inc. Common Stock (SCPS)

About The Company

SCPS Stock Market Logo

Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system. The endocannabinoid system is comprised of chemical compounds, or cannabinoids, that interact with cannabinoid receptors which are located throughout the body. The company product candidates would utilize synthetically-produced cannabinoids as opposed to plant-derived compounds. Its product candidate comprises CO-sTiRNA, which is a STAT3 inhibitor gene therapy and MRI-1867.

IPO Year Sector Industry
2020 Health Care Biotechnology: Pharmaceutical Preparations

Scopus BioPharma Inc. (SCPS) Latest News

Company Contact & Address (SCPS)

Corporate Headquarters Phone Website
New York,
United States
+1 212 479-2513 Official SCPS Website

SCPS Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ SCPS

Jobs & Employment at Scopus BioPharma Inc.

LinkedIn Company Page
Official Career & Employment Page View LinkedIn page for more employment, careers & jobs details.

Related & Similar Stock Symbols

DHY Stock Market Price & News


Credit Suisse High Yield Bond Fund Common …

FUTU Stock Market Price & News


Futu Holdings Limited American Depositary Shares

PLUS Stock Market Price & News


ePlus inc. Common Stock